Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance - nine states, June-August 2021 Journal Article uri icon
Overview
abstract
  • Data on COVID-19 vaccine effectiveness (VE) since the B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating strain in the United States are limited (1-3). CDC used the VISION Network* to examine medical encounters (32,867) from 187 hospitals and 221 emergency departments (EDs) and urgent care (UC) clinics across nine states during June-August 2021, beginning on the date the Delta variant accounted for >50% of sequenced isolates in each medical facility's state. VISION Network methods have been published (4).

  • Link to Article
    publication date
  • 2021
  • Research
    keywords
  • COVID-19 Vaccines
  • Coronavirus Infections
  • Emergency Medicine
  • Hospitalization
  • Prevention
  • Additional Document Info
    volume
  • 70
  • issue
  • 37